Effect of a low-protein diet supplemented with ketoacids on skeletal muscle atrophy and autophagy in rats with type 2 diabetic nephropathy

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Huang, Juan ^a   Wang, Jialin ^a   Gu, Lijie ^a   Bao, Jinfang ^a   Yin, Jun ^a   Tang, Zhihuan ^a   Wang, Ling ^a   Yuan, Weijie ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BECLIN 1; CATHEPSIN L; CREATININE; MESSENGER RNA; NITROGEN; OXOACID; PROTEIN BNIP3; PROTEIN P62; UREA;

ANIMAL EXPERIMENT; ARTICLE; AUTOLYSOSOME; AUTOPHAGOSOME; AUTOPHAGY; BODY WEIGHT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DIET SUPPLEMENTATION; ELECTRON MICROSCOPY; GENE EXPRESSION; MALE; MUSCLE ATROPHY; MUSCLE MASS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN DIET; PROTEIN EXPRESSION; PROTEIN RESTRICTION; PROTEINURIA; RAT; SKELETAL MUSCLE; SOLEUS MUSCLE; TRANSMISSION ELECTRON MICROSCOPY; UREA NITROGEN BLOOD LEVEL;

ANIMALS; AUTOPHAGY; BIOLOGICAL MARKERS; BODY WEIGHT; DIABETIC NEPHROPATHIES; DIET, PROTEIN-RESTRICTED; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; KETO ACIDS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MUSCLE, SKELETAL; MUSCULAR ATROPHY; ORGAN SIZE; PROTEINURIA; RATS; RNA, MESSENGER;

EID: 84896738101     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081464     Document Type: Article

References (63)

1. Aparicio M, Bellizzi V, Chauveau P, Cupisti A, Ecder T, et al. (2012) Protein-restricted diets plus keto/amino acids-a valid therapeutic approach for chronic kidney disease patients. J Ren Nutr 22: S1-21.
2. Dussol B, Iovanna C, Raccah D, Darmon P, Morange S, et al. (2005) A randomized trial of low-protein diet in type 1 and in type 2 diabetes mellitus patients with incipient and overt nephropathy. J Ren Nutr 15: 398-406. (Pubitemid 41405756)
3. Koya D, Haneda M, Inomata S, Suzuki Y, Suzuki D, et al. (2009) Long-term effect of modification of dietary protein intake on the progression of diabetic nephropathy: a randomised controlled trial. Diabetologia 52: 2037-2045.
4. Matsuda S, Iwata K, Takahashi K, Homma H, Tamura Y, et al. (2004) A low-protein diet concomitant with high calorie intake preserves renal function and structure in diabetic OLETF rats. Clin Exp Nephrol 8: 322-330. (Pubitemid 40941108)
5. Velazquez Lopez L, Sil Acosta MJ, Goycochea Robles MV, Torres Tamayo M, Castaneda Limones R (2008) Effect of protein restriction diet on renal function and metabolic control in patients with type 2 diabetes: a randomized clinical trial. Nutr Hosp 23: 141-147. (Pubitemid 351879622)
6. Hansen HP, Tauber-Lassen E, Jensen BR, Parving HH (2002) Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy. Kidney Int 62: 220-228. (Pubitemid 34754065)
7. Giordano M, Lucidi P, Ciarambino T, Gesue L, Castellino P, et al. (2008) Effects of dietary protein restriction on albumin and fibrinogen synthesis in macroalbuminuric type 2 diabetic patients. Diabetologia 51: 21-28. (Pubitemid 50003769)
8. Ciarambino T, Ferrara N, Castellino P, Paolisso G, Coppola L, et al. (2011) Effects of a 6-days-a-week low protein diet regimen on depressive symptoms in young-old type 2 diabetic patients. Nutrition 27: 46-49.
9. Aparicio M, Bellizzi V, Chauveau P, Cupisti A, Ecder T, et al. (2012) Keto acid therapy in predialysis chronic kidney disease patients: final consensus. J Ren Nutr 22: S22-24.
10. Kalantar-Zadeh K, Cano NJ, Budde K, Chazot C, Kovesdy CP, et al. (2011) Diets and enteral supplements for improving outcomes in chronic kidney disease. Nat Rev Nephrol 7: 369-384.
11. Gao X, Huang L, Grosjean F, Esposito V, Wu J, et al. (2011) Low-protein diet supplemented with ketoacids reduces the severity of renal disease in 5/6 nephrectomized rats: a role for KLF15. Kidney Int 79: 987-996.
12. Chauveau P, Barthe N, Rigalleau V, Ozenne S, Castaing F, et al. (1999) Outcome of nutritional status and body composition of uremic patients on a very low protein diet. Am J Kidney Dis 34: 500-507. (Pubitemid 29413623)
13. Aparicio M, Chauveau P, De Precigout V, Bouchet JL, Lasseur C, et al. (2000) Nutrition and outcome on renal replacement therapy of patients with chronic renal failure treated by a supplemented very low protein diet. J Am Soc Nephrol 11: 708-716. (Pubitemid 30171880)
14. Barsotti G, Navalesi R, Morelli E, Giampietro O, Ciardella F, et al. (1987) Effects of a low-phosphorus, low-protein diet supplemented with essential amino acids and keto analogues on 'overt' diabetic nephropathy. Infusionsther Klin Ernahr 14 Suppl 5: 12-16. (Pubitemid 18019005)
15. Barsotti G, Ciardella F, Morelli E, Cupisti A, Mantovanelli A, et al. (1988) Nutritional treatment of renal failure in type 1 diabetic nephropathy. Clin Nephrol 29: 280-287.
16. Fanzani A, Conraads VM, Penna F, Martinet W (2012) Molecular and cellular mechanisms of skeletal muscle atrophy: an update. J Cachexia Sarcopenia Muscle 3: 163-179.
17. Mammucari C, Milan G, Romanello V, Masiero E, Rudolf R, et al. (2007) FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab 6: 458-471. (Pubitemid 350163055)
18. Lecker SH, Jagoe RT, Gilbert A, Gomes M, Baracos V, et al. (2004) Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J 18: 39-51. (Pubitemid 38076464)
19. Janssen U, Riley SG, Vassiliadou A, Floege J, Phillips AO (2003) Hypertension superimposed on type II diabetes in Goto Kakizaki rats induces progressive nephropathy. Kidney Int 63: 2162-2170. (Pubitemid 36605827)
20. Janssen U, Vassiliadou A, Riley SG, Phillips AO, Floege J (2004) The quest for a model of type II diabetes with nephropathy: the Goto Kakizaki rat. J Nephrol 17: 769-773. (Pubitemid 41158295)
21. Gros F, Arnold J, Page N, Decossas M, Korganow AS, et al. (2012) Macroautophagy is deregulated in murine and human lupus T lymphocytes. Autophagy 8: 1113-1123.
22. Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, et al. (2000) LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 19: 5720-5728.
23. Tassa A, Roux MP, Attaix D, Bechet DM (2003) Class III phosphoinositide 3-kinase-Beclin1 complex mediates the amino acid-dependent regulation of autophagy in C2C12 myotubes. Biochem J 376: 577-586. (Pubitemid 38058057)
24. Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, et al. (2007) p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 282: 24131-24145. (Pubitemid 47328003)
25. Kalantar-Zadeh K, Kilpatrick RD, Kuwae N, McAllister CJ, Alcorn H Jr, et al. (2005) Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction. Nephrol Dial Transplant 20: 1880-1888. (Pubitemid 41222603)
26. Jialin W, Yi Z, Weijie Y (2012) Relationship between Body Mass Index and Mortality in Hemodialysis Patients: A Meta-Analysis. Nephron Clin Pract 121: c102-111.
27. de Mutsert R, Grootendorst DC, Axelsson J, Boeschoten EW, Krediet RT, et al. (2008) Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients. Nephrol Dial Transplant 23: 2957-2964.
28. Noori N, Kopple JD, Kovesdy CP, Feroze U, Sim JJ, et al. (2010) Mid-arm muscle circumference and quality of life and survival in maintenance hemodialysis patients. Clin J Am Soc Nephrol 5: 2258-2268.
29. Carrero JJ, Chmielewski M, Axelsson J, Snaedal S, Heimburger O, et al. (2008) Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients. Clin Nutr 27: 557-564.
30. Follmann P, Varga M, Valu L (1993) Ultrastructural changes in the external recti muscles in diabetes mellitus. Doc Ophthalmol 83: 55-64. (Pubitemid 23179171)
31. Pupim LB, Flakoll PJ, Majchrzak KM, Aftab Guy DL, Stenvinkel P, et al. (2005) Increased muscle protein breakdown in chronic hemodialysis patients with type 2 diabetes mellitus. Kidney Int 68: 1857-1865. (Pubitemid 43169932)
32. Pupim LB, Heimburger O, Qureshi AR, Ikizler TA, Stenvinkel P (2005) Accelerated lean body mass loss in incident chronic dialysis patients with diabetes mellitus. Kidney Int 68: 2368-2374. (Pubitemid 43117817)
33. De Santo NG, Perna A, Cirillo M (2011) Low protein diets are mainstay for management of chronic kidney disease. Front Biosci (Schol Ed) 3: 1432-1442.
34. Cianciaruso B, Pota A, Pisani A, Torraca S, Annecchini R, et al. (2008) Metabolic effects of two low protein diets in chronic kidney disease stage 4-5 - a randomized controlled trial. Nephrol Dial Transplant 23: 636-644. (Pubitemid 351767610)
35. Di Iorio BR, Minutolo R, De Nicola L, Bellizzi V, Catapano F, et al. (2003) Supplemented very low protein diet ameliorates responsiveness to erythropoietin in chronic renal failure. Kidney Int 64: 1822-1828. (Pubitemid 37323713)
36. Zatz R, Meyer TW, Rennke HG, Brenner BM (1985) Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci U S A 82: 5963-5967. (Pubitemid 16218883)
37. Brodsky IG, Robbins DC, Hiser E, Fuller SP, Fillyaw M, et al. (1992) Effects of low-protein diets on protein metabolism in insulin-dependent diabetes mellitus patients with early nephropathy. J Clin Endocrinol Metab 75: 351-357.
38. Robertson L, Waugh N, Robertson A (2007) Protein restriction for diabetic renal disease. Cochrane Database Syst Rev: CD002181.
39. Meloni C, Tatangelo P, Cipriani S, Rossi V, Suraci C, et al. (2004) Adequate protein dietary restriction in diabetic and nondiabetic patients with chronic renal failure. J Ren Nutr 14: 208-213. (Pubitemid 39360976)
40. Diaz M, Kleinknecht C, Broyer M (1975) Growth in experimental renal failure: role of calorie and amino acid intake. Kidney Int 8: 349-354.
41. Walser M (1975) Nutritional effects of nitrogen-free analogues of essential amino acids. Life Sci 17: 1011-1020.
42. Dobrowolny G, Aucello M, Rizzuto E, Beccafico S, Mammucari C, et al. (2008) Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. Cell Metab 8: 425-436.
43. Zhao J, Brault JJ, Schild A, Cao P, Sandri M, et al. (2007) FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab 6: 472-483. (Pubitemid 350163056)
44. Sacheck JM, Hyatt JP, Raffaello A, Jagoe RT, Roy RR, et al. (2007) Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases. FASEB J 21: 140-155. (Pubitemid 46052553)
45. Smuder AJ, Kavazis AN, Min K, Powers SK (2011) Exercise protects against doxorubicin-induced markers of autophagy signaling in skeletal muscle. J Appl Physiol 111: 1190-1198.
46. Fanzani A, Zanola A, Rovetta F, Rossi S, Aleo MF (2011) Cisplatin triggers atrophy of skeletal C2C12 myotubes via impairment of Akt signalling pathway and subsequent increment activity of proteasome and autophagy systems. Toxicol Appl Pharmacol 250: 312-321.
47. Mofarrahi M, Sigala I, Guo Y, Godin R, Davis EC, et al. (2012) Autophagy and skeletal muscles in sepsis. PLoS One 7: e47265.
48. Carmignac V, Svensson M, Korner Z, Elowsson L, Matsumura C, et al. (2011) Autophagy is increased in laminin alpha2 chain-deficient muscle and its inhibition improves muscle morphology in a mouse model of MDC1A. Hum Mol Genet 20: 4891-4902.
49. Doyle A, Zhang G, Abdel Fattah EA, Eissa NT, Li YP (2011) Toll-like receptor 4 mediates lipopolysaccharide-induced muscle catabolism via coordinate activation of ubiquitin-proteasome and autophagy-lysosome pathways. FASEB J 25: 99-110.
50. Sandri M (2010) Autophagy in skeletal muscle. FEBS Lett 584: 1411-1416.
51. Anthony JC, Yoshizawa F, Anthony TG, Vary TC, Jefferson LS, et al. (2000) Leucine stimulates translation initiation in skeletal muscle of postabsorptive rats via a rapamycin-sensitive pathway. J Nutr 130: 2413-2419.
52. Blomstrand E, Eliasson J, Karlsson HK, Kohnke R (2006) Branched-chain amino acids activate key enzymes in protein synthesis after physical exercise. J Nutr 136: 269S-273S. (Pubitemid 43156522)
53. Nair KS, Schwartz RG, Welle S (1992) Leucine as a regulator of whole body and skeletal muscle protein metabolism in humans. Am J Physiol 263: E928-934.
54. Glynn EL, Fry CS, Drummond MJ, Timmerman KL, Dhanani S, et al. (2010) Excess leucine intake enhances muscle anabolic signaling but not net protein anabolism in young men and women. J Nutr 140: 1970-1976.
55. Yamamoto D, Maki T, Herningtyas EH, Ikeshita N, Shibahara H, et al. (2010) Branched-chain amino acids protect against dexamethasone-induced soleus muscle atrophy in rats. Muscle Nerve 41: 819-827.
56. Sugawara T, Ito Y, Nishizawa N, Nagasawa T (2009) Regulation of muscle protein degradation, not synthesis, by dietary leucine in rats fed a protein-deficient diet. Amino Acids 37: 609-616.
57. Motil KJ, Matthews DE, Bier DM, Burke JF, Munro HN, et al. (1981) Wholebody leucine and lysine metabolism: response to dietary protein intake in young men. Am J Physiol 240: E712-721. (Pubitemid 11083398)
58. Bernhard J, Beaufrere B, Laville M, Fouque D (2001) Adaptive response to a low-protein diet in predialysis chronic renal failure patients. J Am Soc Nephrol 12: 1249-1254. (Pubitemid 32472639)
59. Goodship TH, Mitch WE, Hoerr RA, Wagner DA, Steinman TI, et al. (1990) Adaptation to low-protein diets in renal failure: leucine turnover and nitrogen balance. J Am Soc Nephrol 1: 66-75.
60. Aparicio M (2009) Protein intake and chronic kidney disease: literature review, 2003 to 2008. J Ren Nutr 19: S5-8.
61. Walser M (1975) Ketoacids in the treatment of uremia. Clin Nephrol 3: 180-186.
62. Chang JH, Kim DK, Park JT, Kang EW, Yoo TH, et al. (2009) Influence of ketoanalogs supplementation on the progression in chronic kidney disease patients who had training on low-protein diet. Nephrology (Carlton) 14: 750-757.
63. Gao X, Wu J, Dong Z, Hua C, Hu H, et al. (2010) A low-protein diet supplemented with ketoacids plays a more protective role against oxidative stress of rat kidney tissue with 5/6 nephrectomy than a low-protein diet alone. Br J Nutr 103: 608-616.